Healthcare entity

Emulate, Inc.

Company

Every one of those 1 sits in a single category, regulation. Of the tracked stories, 1 of 1 also mention Environmental Protection Agency (EPA), the most common co-covered peer. The tracked stories average 2 original sources each. Emulate, Inc. appears in 1 tracked Healthcare story from March 8, 2026.

Last mentioned: Mar 8, 2026

Entity pulse

Recent coverage · Emulate, Inc.

1 story
7 avg impact
100% positive
0% negative

Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.

  • 100% positive

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about Emulate, Inc.

Every one of those 1 sits in a single category, regulation. Of the tracked stories, 1 of 1 also mention Environmental Protection Agency (EPA), the most common co-covered peer. The tracked stories average 2 original sources each. Emulate, Inc. appears in 1 tracked Healthcare story from March 8, 2026.

Stories tracked
1
Sources per story
2

Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 15 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering Emulate, Inc.. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. Industry Consensus

    Scientific American and other major outlets report a definitive decline in global animal experiment volumes.

  2. Major CRO Pivot

    Leading Contract Research Organizations announce multi-million dollar investments in digital twin and OOC labs.

  3. FDA Guidance on NAMs

    The FDA issues initial framework for the submission of data derived from microphysiological systems.

  4. FDA Modernization Act 2.0

    President Biden signs legislation ending the mandate for animal testing for new drug applications.

Stories mentioning Emulate, Inc. 1

Health Policy Positive

The Post-Animal Era: Regulatory Shifts and Tech Innovation Disrupt Drug R&D

The long-standing paradigm of animal experimentation is facing an unprecedented decline as regulatory frameworks and advanced biotechnologies converge. Following the landmark FDA Modernization Act 2.0, the industry is pivoting toward 'New Approach Methodologies' that promise higher human predictive value and lower development costs.

2 sources

Emulate, Inc. is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.

See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.